EGFR and adenocarcinoma: Whilst the regulation of EGFR activity by sortilin [22] seems to be the most plausible explanation behind this, given that EGFR signalling in the lung has more important clinical significance for adenocarcinomas, it can be considered highly probable that more pathways are involved.